Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (26982)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Oct 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2018 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 126 | 28.3% |
| 2 | 66 | 14.8% | |
| 3 | China | 60 | 13.5% |
| 4 | France | 26 | 5.8% |
| 5 | Germany | 18 | 4% |
| 6 | Canada | 15 | 3.4% |
| 7 | Italy | 14 | 3.1% |
| 8 | Japan | 11 | 2.5% |
| 9 | Australia | 8 | 1.8% |
| 10 | Brazil | 8 | 1.8% |
| 11 | Ireland | 7 | 1.6% |
| 12 | New Zealand | 7 | 1.6% |
| 13 | Spain | 7 | 1.6% |
| 14 | United Kingdom | 7 | 1.6% |
| 15 | India | 6 | 1.3% |
| 16 | Netherlands | 5 | 1.1% |
| 17 | Poland | 5 | 1.1% |
| 18 | Norway | 4 | 0.9% |
| 19 | Ivory Coast | 4 | 0.9% |
| 20 | Colombia | 3 | 0.7% |
| 21 | Czechia | 3 | 0.7% |
| 22 | Finland | 3 | 0.7% |
| 23 | Argentina | 3 | 0.7% |
| 24 | Thailand | 3 | 0.7% |
| 25 | Turkey | 3 | 0.7% |
| 26 | Saudi Arabia | 2 | 0.4% |
| 27 | Hong Kong | 2 | 0.4% |
| 28 | Hungary | 2 | 0.4% |
| 29 | Denmark | 2 | 0.4% |
| 30 | Bulgaria | 2 | 0.4% |
| 31 | Burkina Faso | 1 | 0.2% |
| 32 | Egypt | 1 | 0.2% |
| 33 | Estonia | 1 | 0.2% |
| 34 | Guatemala | 1 | 0.2% |
| 35 | Indonesia | 1 | 0.2% |
| 36 | Mexico | 1 | 0.2% |
| 37 | Morocco | 1 | 0.2% |
| 38 | Peru | 1 | 0.2% |
| 39 | Philippines | 1 | 0.2% |
| 40 | Republic of Korea | 1 | 0.2% |
| 41 | Russia | 1 | 0.2% |
| 42 | Sweden | 1 | 0.2% |
| 43 | Taiwan | 1 | 0.2% |
| 44 | Vietnam | 1 | 0.2% |